Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Actinium Pharmaceuticals (7AY1) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Cyclophosphamide, Fludarabine, 131I-Apamistamab, Total Body Irradiation (Tbi), Allogeneic Hematopoietic Stem Cell Transplant (Hsct)Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Acute Leukemia, Myeloid Leukemia, Myelogenous Leukemia, Myelogenous Leukemia, Acute, Acute Myeloid Leukemia, In Relapse, Myelogenous Leukemia In Relapse, Transplant-Related Disorder, Allogeneic Disease, Refractory Amlphase2AndPhase3Not Yet RecruitingRadioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML (RADAR)Aug 28, 2025
Venetoclax, Azacitidine, Lintuzumab-Ac225Acute Myeloid Leukemia, Relapsed Adult Amlphase1AndPhase2WithdrawnVenetoclax, Azacitidine, and Lintuzumab-Ac225 in AML PatientsApr 17, 2019―
Venetoclax, Spironolactone, Lintuzumab-Ac225Acute Myeloid Leukemia, Relapsed Adult Amlphase1AndPhase2UnknownVenetoclax and Lintuzumab-Ac225 in AML PatientsMar 06, 2019―
Lintuzumab Ac 225Refractory Multiple MyelomaPhase ITerminatedA Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple MyelomaDec 12, 2016―
Iomab-B, Conventional Care, HctAcute Myeloid Leukemia, Leukemia, Myeloid, Acute, Acute Myelogenous Leukemia, Aml, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute, Leukemia, Acute Myelogenous, Myelogenous Leukemia, Acute, Bone Marrow TransplantPhase IIIActive Not RecruitingStudy of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid LeukemiaJan 22, 2016―
Spironolactone, Cytarabine (Phase 1 Only), Lintuzumab-Ac225, Furosemide (Phase 1 Only)Amlphase1AndPhase2CompletedLintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) PatientsOct 07, 2015―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Actinium Pharmaceuticals (DE:7AY1) have in its pipeline
Actinium Pharmaceuticals DE:7AY1 is currently developing the following drugs: Cyclophosphamide, Fludarabine, 131I-Apamistamab, Total Body Irradiation (Tbi), Allogeneic Hematopoietic Stem Cell Transplant (Hsct), Venetoclax, Azacitidine, Lintuzumab-Ac225, Venetoclax, Spironolactone, Lintuzumab-Ac225, Lintuzumab Ac 225, Iomab-B, Conventional Care, Hct, Spironolactone, Cytarabine (Phase 1 Only), Lintuzumab-Ac225, Furosemide (Phase 1 Only). These drug candidates are in various stages of clinical development as the company works toward FDA approval.